Related references
Note: Only part of the references are listed.Use of Azithromycin and Death from Cardiovascular Causes
Henrik Svanstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Azithromycin and the Risk of Cardiovascular Death
Charles A. Knirsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Azithromycin and the Risk of Cardiovascular Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
In-hospital prescription of QT-prolonging drugs in a cohort of more than 100,000 patients
Rui Baptista et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
ANTIBIOTIC-INDUCED CARDIAC ARRHYTHMIA IN ELDERLY PATIENTS
Elsayed Abo-Salem et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation
Gary Gintant
PHARMACOLOGY & THERAPEUTICS (2011)
Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers
Jorg Taubel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects A Randomized, Crossover, Double-Blind versus Placebo, Moxifloxacin-Controlled Study
Maria Teresa Rosignoli et al.
CLINICAL DRUG INVESTIGATION (2010)
Antimicrobials and the Risk of Torsades de Pointes The Contribution from Data Mining of the US FDA Adverse Event Reporting System
Elisabetta Poluzzi et al.
DRUG SAFETY (2010)
Relation of Increased Short-Term Variability of QT Interval to Congenital Long-QT Syndrome
Martin Hinterseer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period
Emanuel Raschi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome
Hideki Itoh et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2009)
Genomic structure, transcriptional control, and tissue distribution of HERG1 and KCNQ1 genes
Xiaobin Luo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases
Zhi Song et al.
CANADIAN JOURNAL OF CARDIOLOGY (2008)
Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease
Christian Gluud et al.
CARDIOLOGY (2008)
I-Kr channel blockade to unmask occult congenital long QT syndrome
Darwin Jeyaraj et al.
HEART RHYTHM (2008)
Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients
Bradley D. Freeman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Proarrhythmia as a class effect of quinolones:: Increased dispersion of repolarization and triangulation of action potential predict torsades de pointes
Peter Milberg et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2007)
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes
Annukka Lehtonen et al.
HEART RHYTHM (2007)
Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman
M. Hinterseer et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability
Todd Wisialowski et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Hospital consumption of antibiotics in 15 European countries: results of the ESAC retrospective data collection (1997-2002)
R. H. VanderStichele et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Torsades de pointes induced by antibiotics
Dan Justo et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Frequency of high-risk use of QT-prolonging medications
Nancy M. Allen LaPointe et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin
Ari J. Alexandrou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Erythromycin block of the HERG K+ channel:: Accessibility to F656 and Y652
RS Duncan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The Effects of Intravenous Levofloxacin on the QT Interval and QT Dispersion
Salman Haq et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2006)
Electrophysiological safety of novel fluoroquinolone antibiotic agents gemifloxacin and balofloxacin
Dong Seop Kim et al.
DRUG AND CHEMICAL TOXICOLOGY (2006)
Effects of three Fluoroquinolones on QT analysis after standard treatment courses
JP Tsikouris et al.
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2006)
Long QT syndrome: reduced repolarization reserve and the genetic link
DM Roden
JOURNAL OF INTERNAL MEDICINE (2006)
A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia
J Morganroth et al.
CHEST (2005)
QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome
X Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37°C and 42°C
JQ Guo et al.
HEART RHYTHM (2005)
Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil
T Aiba et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients
ADC Paulussen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Oral erythromycin and the risk of sudden death from cardiac causes
WA Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (IKr) channel
C Davie et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2004)
Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings
GJ Noel et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
Effects of three fluoroquinolones on QT interval in healthy adults after single doses
GJ Noel et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients
LH Curtis et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel
SJC Stanat et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarizations and Torsade de Pointes
P Milberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Drug-induced Long-QT syndrome associated with a subclinical SCN5A mutation
N Makita et al.
CIRCULATION (2002)
Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics
WA Volberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Gender differences in the long QT syndrome:: effects of β-adrenoceptor blockade
CE Conrath et al.
CARDIOVASCULAR RESEARCH (2002)
Rates of Torsades de Pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin
R Frothingham
PHARMACOTHERAPY (2001)
A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia
T Hagiwara et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2001)
Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration
TW Koh
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2001)
Native and cloned ion channels from human heart: laboratory models for evaluating the cardiac safety of new drugs
I Cavero et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2001)
A structural basis for drug-induced long QT syndrome
JS Mitcheson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Effects of fluoroquinolones on HERG currents
U Bischoff et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration
L Patmore et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
